The global primary care POC diagnostics market size
is expected to reach USD 8.6 billion by 2025, according to a new report by
Grand View Research, Inc., registering a 3.5% CAGR during the forecast period.
Flexible and forward-thinking core molecular labs have been embracing and
supporting the use of POC tests to move screening of many common targets to
hospital receiving rooms and physicians’ offices.
As per a study conducted by the American
Journal of Clinical Pathology in 2014, it was found that POC testing improved
clinical operations for manufacturers by reducing follow-up calls and letters
of patients by 85.0% and 89.0%, respectively, and reducing their follow-up
visits by 61.0%. It was also observed that the number of tests ordered
decreased by 21.0%.
Furthermore, rise in the number of tests
receiving a waived status under the Clinical Laboratory Improvement Amendments
of 1988 (CLIA) is anticipated to aid market growth. Researchers and
manufacturers are increasingly recommending these tests owing to cost reduction
of about USD 12-15 per patient and reduction in follow up tests by about 50.0%.
However, there is a massive overlap between different methods and their areas
of usage. For instance, panels to measure glucose and quick international
normalized ratio tests were originally meant for self-testing but are now used
in hospitals and primary settings instead.
To request a sample copy
or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/primary-care-poc-diagnostics-market
https://www.grandviewresearch.com/industry-analysis/primary-care-poc-diagnostics-market
Further key findings from the report suggest:
· By product, the glucose testing segment
accounted for the largest market share owing to rising availability of a large
number of products for glucose testing that can be employed within primary care
settings
· Increase in out-patient practices for lipid
testing as part of a routine checkup is expected to positively enhance the
adoption rate of lipid testing in the market, giving it a prominent spot in the
overall market by product
· In terms of end use, while collaborative
research for advanced and more accurate POC testing kits by research institutes
and biotech firms is likely to facilitate the physicians’ office segment,
government initiatives and projects to extend primary care facilities will
boost the non-practice clinics segment
· The North America primary care POC
diagnostics market is more developed compared to the rest of the world. The
regional segment is fueled by availability of several innovative and advanced
POC diagnostic products and growing awareness and demand for point-of-care
diagnostics in primary home healthcare and assisted healthcare
· The U.S. market is witnessing a shift
toward increasing patient involvement in home care, home-based tests, and
monitoring instruments. In addition, digitalization, EHR, telemedicine, and
web-enabled solutions of monitoring data are gaining pace in U.S., thereby
driving its growth
· Some of the prominent players in the market
are Quidel Corporation, Abbott Laboratories, Instrumentation Laboratory, BD
Biosciences, Roche Diagnostics, Danaher Corporation, Siemens Healthcare, and
bioMerieux.
Grand View Research has segmented the
global primary care POC diagnostics market on the basis of products, end use,
and region:
Primary Care POC Diagnostics Product
Outlook (Revenue, USD Million, 2014 - 2025)
·
Glucose Testing
·
Hb1Ac Testing
·
Coagulation
·
Fertility
·
Infectious Diseases
·
Cardiac Markers
·
Thyroid Stimulating Hormone
·
Hematology
·
Primary Care Systems
·
Decentralized Clinical Chemistry
·
Feces
·
Lipid Testing
·
Cancer Marker
·
Blood Gas/Electrolytes
·
Ambulatory Chemistry
·
Drug Abuse Testing
·
Urinalysis
Primary Care POC Diagnostics End-use
Outlook (Revenue, USD Million, 2014 - 2025)
·
Pharmacy & Retail Clinics
o
Pharmacy & Retail Clinics, By Product
o
Glucose Testing
o
Hb1Ac Testing
o
Coagulation
o
Fertility
o
Infectious Diseases
o
Cardiac Markers
o
Thyroid Stimulating Hormone
o
Hematology
o
Primary Care Systems
o
Decentralized Clinical Chemistry
o
Feces
o
Lipid Testing
o
Cancer Marker
o
Blood Gas/Electrolytes
o
Ambulatory Chemistry
o
Drug Abuse Testing
o
Urinalysis
·
Physician Office
o
Physician Office, By Product
o
Glucose Testing
o
Hb1Ac Testing
o
Coagulation
o
Fertility
o
Infectious Diseases
o
Cardiac Markers
o
Thyroid Stimulating Hormone
o
Hematology
o
Primary Care Systems
o
Decentralized Clinical Chemistry
o
Feces
o
Lipid Testing
o
Cancer Marker
o
Blood Gas/Electrolytes
o
Ambulatory Chemistry
o
Drug Abuse Testing
o
Urinalysis
·
Urgent Care Clinics
o
Urgent Care Clinics, By Product
o
Glucose Testing
o
Hb1Ac Testing
o
Coagulation
o
Fertility
o
Infectious Diseases
o
Cardiac Markers
o
Thyroid Stimulating Hormone
o
Hematology
o
Primary Care Systems
o
Decentralized Clinical Chemistry
o
Feces
o
Lipid Testing
o
Cancer Marker
o
Blood Gas/Electrolytes
o
Ambulatory Chemistry
o
Drug Abuse Testing
o
Urinalysis
·
Non-practice Clinics
o
Non-practice Clinics, By Product
o
Glucose Testing
o
Hb1Ac Testing
o
Coagulation
o
Fertility
o
Infectious Diseases
o
Cardiac Markers
o
Thyroid Stimulating Hormone
o
Hematology
o
Primary Care Systems
o
Decentralized Clinical Chemistry
o
Feces
o
Lipid Testing
o
Cancer Marker
o
Blood Gas/Electrolytes
o
Ambulatory Chemistry
o
Drug Abuse Testing
o
Urinalysis
Primary Care POC Diagnostics Regional
Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
France
o
U.K.
o
Italy
o
Spain
·
Asia Pacific
o
China
o
Japan
o
India
o
Korea
o
Australia
o
Singapore
·
Latin America
o
Brazil
o
Mexico
o
Chile
o
Argentina
·
Middle East & Africa
o
South Africa
o
Saudi Arabia
o
UAE
o
Nigeria
o
Qatar
o
Kenya
o
Zimbabwe
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
